Literature DB >> 1927600

Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation.

A Kruse1, K G Cesarini, F W Bach, L Persson.   

Abstract

In 15 patients without acute brain injury the concentrations of Neuron-specific Enolase (NSE), S-100 Protein (S-100), Creatine Kinase (CK), and Creatine Kinase BB isoenzyme (CK-BB) in ventricular cerebrospinal fluid (CSF) were measured immediately after lateral ventricle cannulation for diagnostic or treatment purposes. From patients who were treated with a shunt another CSF sample was obtained one week after shunt implantation by puncture of the antechamber of the valve. The CSF concentrations of NSE, S-100, CK and CK-BB after cannulation were found to be of the same order as found in patients with severe head injury, stroke or subarachnoid haemorrhage. One week after shunt implantation the concentrations of S-100, CK and CK-BB had returned to normal levels in almost all patients, while the NSE concentrations remained elevated. These findings indicate that the sampling procedure may result in contamination of CSF with NSE, S-100, CK and CK-BB and they should be taken into account in the prognostic evaluation of enzyme concentrations after brain injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1927600     DOI: 10.1007/bf01400675

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  21 in total

1.  Improved outcome prediction based on CSF extrapolated creatine kinase BB isoenzyme activity and other risk factors in severe head injury.

Authors:  P Hans; A Albert; C Franssen; J Born
Journal:  J Neurosurg       Date:  1989-07       Impact factor: 5.115

Review 2.  Chemistry and biology of two proteins, S-100 and 14-3-2, specific to the nervous system.

Authors:  B W Moore
Journal:  Int Rev Neurobiol       Date:  1972       Impact factor: 3.230

3.  Bioluminescent assay of total and brain-specific creatine kinase activity in cerebrospinal fluid.

Authors:  T Halonen; V Näntö; H Frey; T Lövgren
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

4.  Determination of brain enolase isozymes with an enzyme immunoassay at the level of single neurons.

Authors:  K Kato; F Suzuki; R Semba
Journal:  J Neurochem       Date:  1981-10       Impact factor: 5.372

5.  Immunohistochemical localization of creatine kinase-BB isoenzyme to astrocytes in human brain.

Authors:  R J Thompson; P A Kynoch; J Sarjant
Journal:  Brain Res       Date:  1980-11-17       Impact factor: 3.252

6.  Relationship between CT attenuation changes and post-traumatic CSF-CKBB-activity after severe head injury in man.

Authors:  L Rabow; D Cook; M H Lipper; A A DeSalles; H D Gruemer; A Marmarou; D P Becker
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

7.  Pathophysiology of cerebrospinal fluid in head injury: Part 2. Biochemical markers for central nervous system trauma.

Authors:  R A Bakay; K M Sweeney; J H Wood
Journal:  Neurosurgery       Date:  1986-03       Impact factor: 4.654

8.  The regional variability of enzymes in the brain: relevance to CSF enzyme determinations.

Authors:  D A Armbruster; H D Gruemer
Journal:  Clin Chim Acta       Date:  1988-07-29       Impact factor: 3.786

9.  CSF brain creatine kinase levels and lactic acidosis in severe head injury.

Authors:  L Rabow; A F DeSalles; D P Becker; M Yang; H A Kontos; J D Ward; R J Moulton; G Clifton; H D Gruemer; J P Muizelaar
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

10.  The diagnostic value of measuring creatine kinase BB activity in cerebrospinal fluid following acute head injury.

Authors:  H K Nordby; P Urdal
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more
  7 in total

1.  The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China.

Authors:  Meng-Na Lv; Hong Zhang; Yi Shu; Shan Chen; Yuan-Yuan Hu; Min Zhou
Journal:  Transl Neurosci       Date:  2016-02-18       Impact factor: 1.757

2.  Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids.

Authors:  Gretchen M Brophy; Stefania Mondello; Linda Papa; Steven A Robicsek; Andrea Gabrielli; Joseph Tepas; Andras Buki; Claudia Robertson; Frank C Tortella; Ronald L Hayes; Kevin K W Wang
Journal:  J Neurotrauma       Date:  2011-04-08       Impact factor: 5.269

3.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  Ventricular tapping seems to have no influence on S-100B and NSE serum concentrations.

Authors:  Chris Woertgen; Ruth Albert; Markus Köhler; Angela Rzepecki; Ralf Dirk Rothoerl; Thomas Bein; Alexander Brawanski
Journal:  Neurosurg Rev       Date:  2004-05-01       Impact factor: 3.042

5.  Biomarkers in chronic adult hydrocephalus.

Authors:  Andrew Tarnaris; Laurence D Watkins; Neil D Kitchen
Journal:  Cerebrospinal Fluid Res       Date:  2006-10-04

Review 6.  Reliability of S100B in predicting severity of central nervous system injury.

Authors:  Stephen M Bloomfield; James McKinney; Les Smith; Jonathan Brisman
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

7.  A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury.

Authors:  Jae Yoon Lee; Cheol Young Lee; Hong Rye Kim; Chang-Hyun Lee; Hyun Woo Kim; Jong Hyun Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.